| Advice Pool |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Is Leadership Training Worth the Investment? |
|
Advice Pool - Is Leadership Training Worth the Investment?
Leaders are people who achieve results. Leaders are those whose
attitudes and actions lead to positive results. According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product Sending your staff
to leadership training may not deliver the goods you're looking
for! It helps them build a f ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in oundation for achieving the objectives,
if they get to implement the knowledge. Some never do. I've spent time lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ith several organizations who send people to fancy
schools and programs. When I say fancy, I mean high end fancy here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe , like
creepers on walls fancy. Does that mean it will make your team into
leaders. Maybe. No guarantees. Execu d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro tive programs are designed to
make schools successful, not your company, or your staff. Leaders and potential l ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc aders need to be challenged to produce
results. They need goals or objectives to achieve. They need to
show the easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ir staff and team members they have what it takes. They
don't have to actually do everything to achieve the resu nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically lts but
they need to put a plan into action and see it thorough to
completion. Leaders produce results!! That' and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ it. Remember how Audey Murphy took the machine gun nest, the rest was history? Yeah? He produced results. His ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi attitude and actions made
him successful. Yes he had good training along the way. But his
attitude and actions ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a lead him to achieve positive results. Those
that realized he had what it takes followed him. Business leadershi dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod is exactly the same. You need to set people up
to succeed. Developing a process where by team members can set
cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin goals and objectives that meet the organizations overall strategic
plan. Potential leaders that were successful tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen in one area are often
not successful in their new promotion. Well, they have not really
defined their own strat t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel gy for execution of corporate and their own
goals. Until they do they will flop around like a fish out of water. ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust So what do you do? Leadership teams need to analyze their past performance and learn from their results. De y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products velop a positive attitude to their success
Figure out what areas they will need to be most effective
Then plan . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de their actions for the year for each area
Develop a plan to implement each item in the most efficient manner
- s elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip elect the top 10 only.
Work the plan
Enjoy the success Those that make it work are the leaders to be respected tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Payroll Rhode Island, Unique Aspects of Rhode Island Payroll Law and Practice Could Your Area Support Another Local Newspaper? 4 Reasons Why Small Businesses Succeed (or Fail)
|